(Q37419836)

20 August 2017

1 reference

title

Alternative strategies for Clostridium difficile infection (English)

1 reference

20 August 2017

Clostridium difficile

0 references

author name string

Martijn P Bauer

series ordinal

1

1 reference

PubMed ID

19303571

20 August 2017

Jaap T van Dissel

series ordinal

2

1 reference

20 August 2017

1 March 2009

1 reference

International Journal of Antimicrobial Agents

20 August 2017

1 reference

20 August 2017

33 Suppl 1

1 reference

20 August 2017

S51-6

1 reference

Measures to control and prevent Clostridium difficile infection

20 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2809%2970018-4

7 January 2021

Treatment of Clostridium difficile infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2809%2970018-4

7 January 2021

Alternative treatments for Clostridium difficile disease: what really works?

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2809%2970018-4

7 January 2021

Clostridium difficile infection: responses, relapses and re-infections

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2809%2970018-4

7 January 2021

A randomized placebo-controlled trial of Saccharomyces boulardii in combination with standard antibiotics for Clostridium difficile disease

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2809%2970018-4

7 January 2021

Tolevamer, a novel nonantibiotic polymer, compared with vancomycin in the treatment of mild to moderately severe Clostridium difficile-associated diarrhea

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2809%2970018-4

7 January 2021

Randomized controlled trial of colestipol in antibiotic-associated colitis

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2809%2970018-4

7 January 2021

Bovine antibody-enriched whey to aid in the prevention of a relapse of Clostridium difficile-associated diarrhoea: preclinical and preliminary clinical data.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2809%2970018-4

7 January 2021

Clostridium difficile-associated diarrhoea: bovine anti-Clostridium difficile whey protein to help aid the prevention of relapses

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2809%2970018-4

7 January 2021

The search for a better treatment for recurrent Clostridium difficile disease: use of high-dose vancomycin combined with Saccharomyces boulardii

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2809%2970018-4

7 January 2021

Lactobacillus plantarum 299v for the treatment of recurrent Clostridium difficile-associated diarrhoea: a double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2809%2970018-4

7 January 2021

Probiotics for recurrent Clostridium difficile disease

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2809%2970018-4

7 January 2021

A randomized, double-blind study comparing Clostridium difficile immune whey and metronidazole for recurrent Clostridium difficile-associated diarrhoea: efficacy and safety data of a prematurely interrupted trial

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2809%2970018-4

7 January 2021

Successful treatment of relapsing Clostridium difficile colitis with Lactobacillus GG

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2809%2970018-4

7 January 2021

Treatment of recurrent Clostridium difficile colitis with Lactobacillus GG

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2809%2970018-4

7 January 2021

Bacteriotherapy for chronic relapsing Clostridium difficile diarrhoea in six patients

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2809%2970018-4

7 January 2021

Recurrent Clostridium difficile colitis: case series involving 18 patients treated with donor stool administered via a nasogastric tube

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2809%2970018-4

7 January 2021

Treatment with intravenously administered gamma globulin of chronic relapsing colitis induced by Clostridium difficile toxin

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2809%2970018-4

7 January 2021

Intravenous immunoglobulin for recurrent Clostridium difficile diarrhoea

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2809%2970018-4

7 January 2021

Colonization for the prevention of Clostridium difficile disease in hamsters

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2809%2970018-4

7 January 2021

Probiotics for treatment of Clostridium difficile-associated colitis in adults

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2809%2970018-4

7 January 2021

Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2809%2970018-4

7 January 2021

Descriptive study of intravenous immunoglobulin for the treatment of recurrent Clostridium difficile diarrhoea

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2809%2970018-4

7 January 2021

The safety of whey protein concentrate derived from the milk of cows immunized against Clostridium difficile

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2809%2970018-4

7 January 2021

10.1016/S0924-8579(09)70018-4

Identifiers

DOI

1 reference

20 August 2017

1 reference

PubMed ID

19303571